BTIG Maintains Buy on Jade Biosciences, Raises Price Target to $39

Benzinga Newsdesk www.benzinga.com Positive 80.0%

Neg 0% Neu 0% Pos 80%

BTIG analyst Julian Harrison maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $28 to $39.